239 research outputs found
BSA Practice guidance: an overview of current management of auditory processing disorder (APD)
Identifying Barriers to Estimating Carbon Release From Interacting Feedbacks in a Warming Arctic
The northern permafrost region holds almost half of the world's soil carbon in just 15% of global terrestrial surface area. Between 2007 and 2016, permafrost warmed by an average of 0.29°C, with observations indicating that frozen ground in the more southerly, discontinuous permafrost zone is already thawing. Despite this, our understanding of potential carbon release from this region remains not only uncertain, but incomplete. SROCC highlights that global-scale models represent carbon loss from permafrost only through gradual, top-down thaw. This excludes “pulse” disturbances – namely abrupt thaw, in which frozen ground with high ice content thaws, resulting in subsidence and comparatively rapid ongoing thaw, and fire – both of which are critically important to projecting future permafrost carbon feedbacks. Substantial uncertainty remains around the response of these disturbances to ongoing warming, although both are projected to affect an increasing area of the northern permafrost region. This is of particular concern as recent evidence indicates that pulse disturbances may, in some cases, respond nonlinearly to warming. Even less well understood are the interactions between processes driving loss of permafrost carbon. Fire not only drives direct carbon loss, but can accelerate gradual and abrupt permafrost thaw. However, this important interplay is rarely addressed in the scientific literature. Here, we identify barriers to estimating the magnitude of future emissions from pulse disturbances across the northern permafrost region, including those resulting from interactions between disturbances. We draw on recent advances to prioritize said barriers and suggest avenues for the polar research community to address these
Nucleoside diphosphate kinase A as a controller of AMP-kinase in airway epithelia
This review integrates recent understanding of a novel role for NDPK-A in two related directions: Firstly, its role in an airway epithelial cell when bound to the luminal (apical) membrane and secondly in the cytosol of many different cells (epithelial and non-epithelial) where an isoform-specific interaction occurs with a regulatory partner, AMPKα1. Thus NDPK-A is present in both a membrane and cytosolic environment but in the apical membrane, its roles are not understood in detail; preliminary data suggest that it co-localises with the cystic fibrosis protein (CFTR). In cytosol, we find that NDPK-A is coupled to the catalytic alpha1 isoform of the AMP-activated protein kinase (AMPKα subunit), which is part of a heterotrimeric protein complex that responds to cellular energy status by switching off ATP-consuming pathways and switching on ATP-generating pathways when ATP is limiting. We find that ATP is located within this complex and ‘fed’ from NDPK to AMPK without ever ‘seeing’ bulk solution. Importantly, the reverse can also happen such that AMPK activity can be made to decline when NDPK-A ‘steals’ ATP from AMPK. Thus we propose a novel paradigm in NDPK-A function by suggesting that AMP-kinase can be regulated by NDPK-A, independently of AMP
Women’s experiences of wearing therapeutic footwear in three European countries
Background: Therapeutic footwear is recommended for those people with severe foot problems associated with
rheumatoid arthritis (RA). However, it is known that many do not wear them. Although previous European studies
have recommended service and footwear design improvements, it is not known if services have improved or if this
footwear meets the personal needs of people with RA. As an earlier study found that this footwear has more
impact on women than males, this study explores women’s experiences of the process of being provided with it
and wearing it. No previous work has compared women’s experiences of this footwear in different countries,
therefore this study aimed to explore the potential differences between the UK, the Netherlands and Spain.
Method: Women with RA and experience of wearing therapeutic footwear were purposively recruited. Ten women
with RA were interviewed in each of the three countries. An interpretive phenomenological approach (IPA) was
adopted during data collection and analysis. Conversational style interviews were used to collect the data.
Results: Six themes were identified: feet being visibly different because of RA; the referring practitioners’ approach
to the patient; the dispensing practitioners’ approach to the patient; the footwear being visible as different to
others; footwear influencing social participation; and the women’s wishes for improved footwear services. Despite
their nationality, these women revealed that therapeutic footwear invokes emotions of sadness, shame and anger
and that it is often the final and symbolic marker of the effects of RA on self perception and their changed lives.
This results in severe restriction of important activities, particularly those involving social participation. However,
where a patient focussed approach was used, particularly by the practitioners in Spain and the Netherlands, the
acceptance of this footwear was much more evident and there was less wastage as a result of the footwear being
prescribed and then not worn. In the UK, the women were more likely to passively accept the footwear with the
only choice being to reject it once it had been provided. All the women were vocal about what would improve
their experiences and this centred on the consultation with both the referring practitioner and the practitioner that
provides the footwear.
Conclusion: This unique study, carried out in three countries has revealed emotive and personal accounts of what
it is like to have an item of clothing replaced with an ‘intervention’. The participant’s experience of their
consultations with practitioners has revealed the tension between the practitioners’ requirements and the women’s
‘social’ needs. Practitioners need greater understanding of the social and emotional consequences of using
therapeutic footwear as an intervention
The effects of junction interdiffusion and misfit dislocations on the efficiency of highly mismatched heterojunction photovoltaic devices
The cystic fibrosis transmembrane recruiter the alter ego of CFTR as a multi-kinase anchor
This review focuses on a newly discovered interaction between protein kinases involved in cellular energetics, a process that may be disturbed in cystic fibrosis for unknown reasons. I propose a new model where kinase-mediated cellular transmission of energy provides mechanistic insight to a latent role of the cystic fibrosis transmembrane conductance regulator (CFTR). I suggest that CFTR acts as a multi-kinase recruiter to the apical epithelial membrane. My group finds that, in the cytosol, two protein kinases involved in cell energy homeostasis, nucleoside diphosphate kinase (NDPK) and AMP-activated kinase (AMPK), bind one another. Preliminary data suggest that both can also bind CFTR (function unclear). The disrupted role of this CFTR-kinase complex as ‘membrane transmitter to the cell’ is proposed as an alternative paradigm to the conventional ion transport mediated and CFTR/chloride-centric view of cystic fibrosis pathogenesis. Chloride remains important, but instead, chloride-induced control of the phosphohistidine content of one kinase component (NDPK, via a multi-kinase complex that also includes a third kinase, CK2; formerly casein kinase 2). I suggest that this complex provides the necessary near-equilibrium conditions needed for efficient transmission of phosphate energy to proteins controlling cellular energetics. Crucially, a new role for CFTR as a kinase controller is proposed with ionic concentration acting as a signal. The model posits a regulatory control relay for energy sensing involving a cascade of protein kinases bound to CFTR
Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS)
<p>Abstract</p> <p>Background</p> <p>While it is recognised that depression is prevalent in Rheumatoid Arthritis (RA), recent studies have also highlighted significant levels of anxiety in RA patients. This study compared two commonly used scales, the Depression Anxiety and Stress Scale (DASS) and the Hospital Anxiety and Depression Scale (HADS), in relation to their measurement range and cut points to consider the relative prevalence of both constructs, and if prevalence rates may be due to scale-specific case definition.</p> <p>Methods</p> <p>Patients meeting the criteria for RA were recruited in Leeds, UK and Sydney, Australia and asked to complete a survey that included both scales. The data was analysed using the Rasch measurement model.</p> <p>Results</p> <p>A total of 169 RA patients were assessed, with a repeat subsample, resulting in 323 cases for analysis. Both scales met Rasch model expectations. Using the 'possible+probable' cut point from the HADS, 58.3% had neither anxiety nor depression; 13.5% had anxiety only; 6.4% depression only and 21.8% had both 'possible+probable' anxiety and depression. Cut points for depression were comparable across the two scales while a lower cut point for anxiety in the DASS was required to equate prevalence.</p> <p>Conclusions</p> <p>This study provides further support for high prevalence of depression and anxiety in RA. It also shows that while these two scales provide a good indication of possible depression and anxiety, the estimates of prevalence so derived could vary, particularly for anxiety. These findings are discussed in terms of comparisons across studies and selection of scales for clinical use.</p
Measuring the positive psychological well-being of people with rheumatoid arthritis: a cross-sectional validation of the subjective vitality scale
Introduction: People with rheumatoid arthritis (RA) frequently suffer from compromised physical and psychological health, however, little is known about positive indicators of health, due to a lack of validated outcome measures. This study aims to validate a clinically relevant outcome measure of positive psychological well-being for people with RA. The first study examined the reliability and factorial validity of the Subjective Vitality Scale (SVS), whilst study 2 tested the instruments convergent validity. Methods: In study 1, National Rheumatoid Arthritis Society members (N = 333; M age = 59.82 years SD = 11.00) completed a postal questionnaire. For study 2, participants (N = 106; M age = 56 years, SD = 12 years) were those recruited to a randomized control trial comparing two physical activity interventions who completed a range of health-related questionnaires. Results: The SVS had a high level of internal consistency (α = .93, Rho = .92). Confirmatory factor analysis supported the uni-dimensional factor structure of the questionnaire among RA patients [χ = 1327 (10), CFI = 1.0, SRMSR = .01 and RMSEA = .00 (.00 - .08)]. Support for the scales convergent validity was revealed by significant (p < .05) relationships, in expected directions, with health related quality of life (r = .59), physical function (r = .58), feelings of fatigue (r = −.70), anxiety (r = −.57) and depression (r = −.73). Conclusions: Results from two studies have provided support for the internal consistency, factorial structure and convergent validity of the Subjective Vitality Scale. Researchers and healthcare providers may employ this clinically relevant, freely available and brief assessment with the confidence that it is a valid and reliable measure of positive psychological well-being for RA patients
- …